Partner & Investor PortalsCell & Gene Therapy Developers

A decision-ready blueprint

Custom Partner Portals for Cell and Gene Therapy Developers

A partner-facing solution designed around the commercial realities of cell & gene therapy developers.

Two operations leaders review a detailed decision portal in a life-science workspace.
PhD and MBA-led Life Science Consultancy
Principal-led accountability

Scientific, commercial, and digital architecture, with specialist expertise assembled where the engagement requires it.

Cell and gene therapy partnerships depend on controlled exchange of sensitive scientific, manufacturing, clinical, and commercial information. A purpose-built portal gives alliance teams, CDMOs, collaborators, and licensing partners a clear way to work from the right material without relying on fragmented files and email.

Lonrú Consulting designs the portal around the selected partnering workflow, with defined access, review, and delivery ownership from the outset.

A governed operating model for the decision in view.

  1. Lonrú Context Engineering™

    We define the information, roles, source systems, permissions, and partner boundaries for the selected workflow.

  2. Lonrú Agentic Systems™

    Configured systems can structure approved material, prepare milestone views, or support defined review tasks within those controls.

  3. Lonrú Consulting™

    Lonrú provides principal-led product, workflow, and review governance with client SMEs approving work in their accountable areas.

  4. VantagePoint™

    The approved portal becomes a practical partner workspace for controlled exchange, milestones, decisions, and next actions.

What this portal solution can deliver.

  • Control sensitive partner exchange

    Create role-aware access to the material required for diligence, tech transfer, alliance management, or licensing work.

  • Make milestones and obligations visible

    Present agreed clinical, manufacturing, regulatory, and commercial actions in a useful shared view.

  • Connect the right source systems

    Define controlled connections to relevant enterprise platforms without treating the portal as a replacement for systems of record.

  • Improve the partner experience

    Give external collaborators a clear, governed route through the selected workflow.

Design access and accountability first.

The portal is configured around approved information, defined roles, and the controls required for the selected partnership. It does not remove client responsibility for scientific, quality, contractual, or commercial approval.

Confidential partner material remains within the agreed access and sharing boundaries.

Relevant experience

Evidence that informs this work.

Under 8 weeks

Advanced Therapy Partner Portal

Architected and deployed a custom, secure Advanced Therapy Partner Portal for a specialized clinical-stage provider in under 8 weeks, moving legacy spreadsheet-based partner tracking into an automated, role-governed deal-flow engine.

Interactive SaaS

Trial intelligence and VantagePoint™

Engineered and deployed an interactive SaaS trial-tracking platform, VantagePoint Insights™, with an advanced-therapy Voice of Customer database that maps pipeline maturity, modality, and vector dominance for industry stakeholders.

Architecture in context

ActiveArchitecture™ in context

Diagram summary: Partner evidence, roles, milestones, and controlled information exchange are brought together through ActiveArchitecture™ to support governed cell and gene therapy collaboration.

Practical questions

Questions clients raise before a briefing.

Yes, where the selected workflow requires it. We define controlled connections to relevant systems while preserving their role as systems of record.

Next step

Discuss the first useful workstream.

Bring the decision, workflow, or delivery constraint that needs a clearer operating path.

Request a focused briefing
Related Strategic Focus

Cross-Functional Industry Solutions

Explore Full Directory →